Literature DB >> 7623841

A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB.

E Hadzic1, V Desai-Yajnik, E Helmer, S Guo, S Wu, N Koudinova, J Casanova, B M Raaka, H H Samuels.   

Abstract

The effects of the thyroid hormone (3,5,3'-triiodo-L-thyronine [T3]) on gene transcription are mediated by nuclear T3 receptors (T3Rs). alpha- and beta-isoform T3Rs (T3R alpha and -beta) are expressed from different genes and are members of a superfamily of ligand-dependent transcription factors that also includes the receptors for steroid hormones, vitamin D, and retinoids. Although T3 activates transcription by mediating a conformational change in the C-terminal approximately 220-amino-acid ligand-binding domain (LBD), the fundamental mechanisms of T3R-mediated transcriptional activation remain to be determined. We found that deletion of the 50-amino-acid N-terminal A/B domain of chicken T3R alpha (cT3R alpha) decreases T3-dependent stimulation of genes regulated by native thyroid hormone response elements about 10- to 20-fold. The requirement of the A/B region for transcriptional activation was mapped to amino acids 21 to 30, which contain a cluster of five basic amino acids. The A/B region of cT3R alpha is not required for T3 binding or for DNA binding of the receptor as a heterodimer with retinoid X receptor. In vitro binding studies indicate that the N-terminal region of cT3R alpha interacts efficiently with TFIIB and that this interaction requires amino acids 21 to 30 of the A/B region. In contrast, the LBD interacts poorly with TFIIB. The region of TFIIB primarily involved in the binding of cT3R alpha includes an amphipathic alpha helix contained within residues 178 to 201. Analysis using a fusion protein containing the DNA-binding domain of GAL4 and the entire A/B region of cT3R alpha suggests that this region does not contain an intrinsic activation domain. These and other studies indicate that cT3R alpha mediates at least some of its effects through TFIIB in vivo and that the N-terminal region of DNA-bound cT3R alpha acts to recruit and/or stabilize the binding of TFIIB to the transcription complex. T3 stimulation could then result from ligand-mediated changes in the LBD which may lead to the interaction of other factors with cT3R alpha, TFIIB, and/or other components involved in the initiation of transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7623841      PMCID: PMC230690          DOI: 10.1128/MCB.15.8.4507

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

1.  Mutational analysis identifies a new functional domain of the thyroid hormone receptor.

Authors:  A L O'Donnell; R J Koenig
Journal:  Mol Endocrinol       Date:  1990-05

2.  Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.

Authors:  S Selmi; H H Samuels
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

3.  Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein.

Authors:  A L O'Donnell; E D Rosen; D S Darling; R J Koenig
Journal:  Mol Endocrinol       Date:  1991-01

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 5.  Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model.

Authors:  B M Forman; H H Samuels
Journal:  Mol Endocrinol       Date:  1990-09

6.  A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.

Authors:  B M Forman; C R Yang; M Au; J Casanova; J Ghysdael; H H Samuels
Journal:  Mol Endocrinol       Date:  1989-10

7.  A vector for expressing GAL4(1-147) fusions in mammalian cells.

Authors:  I Sadowski; M Ptashne
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

8.  Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone.

Authors:  R A Hodin; M A Lazar; W W Chin
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

9.  Human carboxyl-terminal variant of alpha-type c-erbA inhibits trans-activation by thyroid hormone receptors without binding thyroid hormone.

Authors:  M A Lazar; R A Hodin; W W Chin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

10.  Phosphorylation of the v-erbA protein is required for its function as an oncogene.

Authors:  C Glineur; M Zenke; H Beug; J Ghysdael
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

View more
  32 in total

Review 1.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

2.  Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.

Authors:  H Ma; H Hong; S M Huang; R A Irvine; P Webb; P J Kushner; G A Coetzee; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2.

Authors:  X Cheng; M J Reginato; N C Andrews; M A Lazar
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

4.  Regulation of the mdm2 oncogene by thyroid hormone receptor.

Authors:  J S Qi; Y Yuan; V Desai-Yajnik; H H Samuels
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

5.  Mutational analysis of the D1/E1 core helices and the conserved N-terminal region of yeast transcription factor IIB (TFIIB): identification of an N-terminal mutant that stabilizes TATA-binding protein-TFIIB-DNA complexes.

Authors:  C S Bangur; T S Pardee; A S Ponticelli
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

6.  Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB.

Authors:  J M Yao; D E Breiding; E J Androphy
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.

Authors:  G X Tong; M Jeyakumar; M R Tanen; M K Bagchi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

8.  Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription.

Authors:  A M Moilanen; H Poukka; U Karvonen; M Häkli; O A Jänne; J J Palvimo
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts.

Authors:  L A Crofts; M S Hancock; N A Morrison; J A Eisman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.